To distinguish DLBCL patients from healthy controls in the TCGA_GETx dataset (Fig. 9C), TOP2A (AUC: 0.825), CDK1 (AUC: 0.799) and NEK2 (AUC: 0.782) ranked the top 3 genes. The gene discussed is CDK1; the disease is diffuse large B-cell lymphoma.